664. Are Thousands of Medical Cures Hiding in Plain Sight?

Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle. SOURCES: Chris Snyder , professor of economics at Dartmouth College. David Fajgenbaum , co-founder and president of Every Cure, physician-scientist at the University of Pennsylvania. Heather Stone , health science policy analyst at the Food & Drug Administration. Sarrin Chethik , senior policy analyst at the Market …